WithdrawnNCT00801567
Official study titleA Magnetic Resonance Spectroscopy Study of Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation
This study was withdrawn before enrollment.
In BelmontBipolarity, SchizophreniaDevice studyAges 18–55
- Countries
- United States
- Sponsor
- Mclean Hospital (Hospital / academic medical center)
CompletedNCT01784341
Official study titleCircadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?
This study has finished and is no longer accepting participants.
In ChicagoBipolarity, DepressionObservational studyAges 18–55
- Countries
- United States
- Sponsor
- Northwestern University
CompletedNCT00043654
Official study titleAntiglucocorticoid Therapy in Bipolar Depression With Mifepristone (RU486)
This study has finished and is no longer accepting participants.
In PhiladelphiaBipolarity, DepressionMedication studyAges 18–75
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH) (Government agency)
CompletedNCT05603819
Official study titleClinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood Biomarkers
This study has finished and is no longer accepting participants.
Multiple locations, including CopenhagenBipolarity, DepressionObservational studyAges 18–80
- Countries
- France, Denmark, Spain
- Sponsor
- Alcediag
CompletedNCT00844974
Official study titleCognitive Deficits in Major Depressive Disorder and Bipolar Disorder Depressed Type: Prevalence and Symptoms With Treating of Depressive Symptoms
This study has finished and is no longer accepting participants.
In BostonDepression, BipolarityInterventional studyAges 18+
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
WithdrawnNCT02625779
What is this study about?This study assesses depression symptoms.
This study was withdrawn before enrollment.
In SeoulBipolarity, DepressionMedication studyAges 19–65
- Countries
- South Korea
- Sponsor
- Ewha Womans University Mokdong Hospital
CompletedNCT05936983
Official study titleComparison of Physical Fitness, Physical Activity Level, Depression and Quality of Life in Patients With Bipolar Disorder and Schizophrenia With Healthy Controls
This study has finished and is no longer accepting participants.
In IstanbulBipolarity, SchizophreniaObservational studyAges 30–55
- Countries
- Türkiye
- Sponsor
- Yeditepe University
CompletedNCT00083954
Official study titleA Confirmatory Multicenter, Double-blind, Randomized, Placebo Controlled Study of the Use of Quetiapine Fumarate (SEROQUEL) in the Treatment of Patients With Bipolar Depression
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamBipolarity, DepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- AstraZeneca
CompletedNCT00720369
Official study titleOral Administration of CoQ10 and Phosphorus-31 Magnetization Transfer Magnetic Resonance Spectroscopy in Geriatric Bipolar Disorder and Healthy Older Adults
This study has finished and is no longer accepting participants.
In BelmontBipolarity, DepressionMedication studyAges 55–89
- Countries
- United States
- Sponsor
- Mclean Hospital (Hospital / academic medical center)
CompletedNCT02918097
Official study titleCost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarity, DepressionMedication studyAges 18–65
- Countries
- Sponsor
- Federal University of Rio Grande do Sul
CompletedNCT01655030
Official study titleA Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of Creatine Monohydrate as Adjunctive Therapy for Bipolar Depression
This study has finished and is no longer accepting participants.
In São PauloBipolarity, DepressionPlacebo comparisonAges 18–60
- Countries
- Brazil
- Sponsor
- University of Sao Paulo
CompletedNCT01479829
Official study titleCyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression: Role of Inflammation and Kynurenine Pathway Biomarkers
This study has finished and is no longer accepting participants.
In MaywoodBipolarity, DepressionMedication studyAges 21–65
- Countries
- United States
- Sponsor
- Loyola University